article thumbnail

AI-Scraping Copyright Litigation Comes to Canada (CANLII v Caseway AI)

Hugh Stephens Blog

After all the lawsuits in the US (and some in the UK) pitting various copyright holders against AI development companies alleging the AI platforms were infringing copyright by reproducing and ingesting copyrighted materials without authorization to train their algorithms to produce outputs based on the ingested content–outputs … Continue (..)

article thumbnail

3 Count: Pokemon with Litigation

Plagiarism Today

The post 3 Count: Pokemon with Litigation appeared first on Plagiarism Today. Nintendo sues Palworld developer, judge trims Office Depot's legal fees and Amazon joints the Motion Picture Association.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

3 Count: A Decade of Litigation

Plagiarism Today

The post 3 Count: A Decade of Litigation appeared first on Plagiarism Today. Oracle wins more attorney fees in Rimini case, OpenAI to allow access to training data and Telegram removes Z-Library posts.

article thumbnail

3 Count: Mechanical Litigation

Plagiarism Today

The post 3 Count: Mechanical Litigation appeared first on Plagiarism Today. Spotify sued by Mechanical Licensing Collective, Internet Archive fails to get music lawsuit tossed and Sony Music opts out of AI training.

article thumbnail

AI Litigation Update

Creative Law Center

This post, an AI litigation update, is a snapshot in time looking at what is going on in two of the active cases. The post AI Litigation Update appeared first on Creative Law Center. Legal challenges to generative AI are on the rise.

article thumbnail

3 Count: Humans of Litigation

Plagiarism Today

The post 3 Count: Humans of Litigation appeared first on Plagiarism Today. Humans of New York creator unhappy with Bombay counterpart, Danish man faces prison over hacked streaming accounts and more.

article thumbnail

Update on Pending Denosumab BPCIA Litigations

JD Supra Law

There are four pending BPCIA litigations brought by Amgen against biosimilar companies seeking to market denosumab biosimilars. Two of the four cases are pending in the District Court for the District of New Jersey before Judge O’Hearn: Amgen Inc. Celltrion, Inc., 1:24-cv-06497-CPO-EAP (D.N.J.), filed on May 28, 2024, and Amgen Inc.